| Secondary |
| Hypercholesterolaemia |
31.6% |
| Dyspepsia |
14.5% |
| Hypertension |
14.5% |
| Musculoskeletal Stiffness |
14.5% |
| Pruritus |
3.9% |
| Application Site Irritation |
2.6% |
| Arthralgia |
2.6% |
| Glaucoma |
2.6% |
| Lichen Sclerosus |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Arthropathy |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Plasma Cell Myeloma |
1.3% |
| Psoriasis |
1.3% |
|
| Renal Failure |
50.0% |
| Multi-organ Failure |
18.8% |
| Jaundice |
6.3% |
| Laceration |
6.3% |
| Plasma Cell Myeloma Recurrent |
6.3% |
| Vulval Disorder |
6.3% |
| Wrong Technique In Drug Usage Process |
6.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
48.5% |
| Supplementation Therapy |
6.2% |
| Hypertension |
5.5% |
| Rheumatoid Arthritis |
5.1% |
| Medical Diet |
3.9% |
| Psoriatic Arthropathy |
3.3% |
| Vitamin Supplementation |
2.8% |
| Prophylaxis |
2.6% |
| Pain |
2.2% |
| Psoriasis |
2.2% |
| Blood Cholesterol Increased |
2.1% |
| Depression |
2.1% |
| Crohn's Disease |
1.9% |
| Diabetes Mellitus |
1.9% |
| Metastases To Bone |
1.8% |
| Non-small Cell Lung Cancer |
1.7% |
| Anxiety |
1.5% |
| Osteoarthritis |
1.5% |
| Plasma Cell Myeloma |
1.5% |
| Prostate Cancer |
1.5% |
|
| Pyrexia |
8.8% |
| Death |
5.9% |
| Injection Site Pain |
5.9% |
| Nausea |
5.9% |
| Vertebroplasty |
5.9% |
| Vomiting |
5.9% |
| Convulsion |
4.4% |
| Drug Ineffective |
4.4% |
| Fatigue |
4.4% |
| Headache |
4.4% |
| Oedema Peripheral |
4.4% |
| Pain In Extremity |
4.4% |
| Periorbital Haematoma |
4.4% |
| Restless Legs Syndrome |
4.4% |
| Sinusitis |
4.4% |
| Swelling |
4.4% |
| Tumour Excision |
4.4% |
| Urinary Tract Infection |
4.4% |
| Weight Decreased |
4.4% |
| Weight Increased |
4.4% |
|
| Interacting |
| Hypercholesterolaemia |
34.8% |
| Dyspepsia |
17.4% |
| Hypertension |
17.4% |
| Musculoskeletal Stiffness |
17.4% |
| Blood Cholesterol Increased |
13.0% |
|
| Nausea |
60.0% |
| Pruritus |
20.0% |
| Renal Failure |
20.0% |
|
